Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1,706,820
-
Shares change
-
-211,508
-
Total reported value, excl. options
-
$1,707,136
-
Value change
-
-$245,035
-
Put/Call ratio
-
0%
-
Number of buys
-
8
-
Number of sells
-
-14
-
Price
-
$1.00
Significant Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q2 2022
28 filings reported holding RKDA - Arcadia Biosciences, Inc. - Common Stock as of Q2 2022.
Arcadia Biosciences, Inc. - Common Stock (RKDA) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,706,820 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (789,931 shares), GEODE CAPITAL MANAGEMENT, LLC (176,021 shares), RENAISSANCE TECHNOLOGIES LLC (129,500 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (123,238 shares), STATE STREET CORP (101,800 shares), CITADEL ADVISORS LLC (57,081 shares), WELLS FARGO & COMPANY/MN (43,952 shares), LPL Financial LLC (43,000 shares), HighTower Advisors, LLC (41,736 shares), and MYDA Advisors LLC (40,000 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.